Sign in

CIK 0001812364

  • Large accelerated filer

Relay Therapeutics, Inc.

Sign in to watch
Ticker
RLAY
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 617-370-8837
Business address
60 HAMPSHIRE STREET, CAMBRIDGE, MA, 02139
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$119,185,588
in 10 filings, $2.7M under 10b5-1 plans

Net −$119,185,588. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2026-10-28 Rahmer Peter See remarks Sale −753 $18.62 $14K 222,904
2026-10-28 Bergstrom Donald A President, R&D Sale −2,252 $18.62 $42K 396,878
2026-10-28 Catinazzo Thomas Chief Financial Officer Sale −1,469 $18.62 $27K 103,665
2026-10-07 Patel Sanjiv President and CEO Sale 10b5-1 −48,199 $18.10 $872K 471,301
2026-10-06 Catinazzo Thomas Chief Financial Officer Sale 10b5-1 −17,511 $18.58 $325K 105,340
2026-10-06 Catinazzo Thomas Chief Financial Officer Sale 10b5-1 −206 $19.26 $4K 105,134
2026-09-08 Bergstrom Donald A President, R&D Sale 10b5-1 −8,530 $18.97 $162K 399,130
2026-09-08 Catinazzo Thomas Chief Financial Officer Sale 10b5-1 −17,717 $18.94 $336K 122,851
2026-09-08 Patel Sanjiv President and CEO Sale 10b5-1 −48,199 $18.94 $913K 519,500
2026-08-26 Rahmer Peter See remarks Sale 10b5-1 −4,508 $20.03 $90K 223,657
2026-08-25 SVF Pauling (Cayman) Ltd 10% owner Sale −6,000,000 $19.40 $116.4M 21,904,963
2026-08-17 Patel Sanjiv President and CEO Sale 10b5-1 −48,199 $20.33 $980K 567,699
2026-08-14 Catinazzo Thomas Chief Financial Officer Sale 10b5-1 −17,717 $19.74 $350K 140,568
2026-07-28 Catinazzo Thomas Chief Financial Officer Sale −1,459 $18.61 $27K 158,285
2026-07-28 Rahmer Peter See remarks Sale −748 $18.61 $14K 228,165
2026-07-28 Bergstrom Donald A President, R&D Sale −2,237 $18.61 $42K 407,660
2026-07-07 Patel Sanjiv President and CEO Sale 10b5-1 −48,199 $19.58 $944K 615,898
2026-07-06 Bergstrom Donald A President, R&D Sale 10b5-1 −8,660 $18.71 $162K 409,897
2026-07-06 Catinazzo Thomas Chief Financial Officer Sale 10b5-1 −17,717 $18.69 $331K 159,744
2026-06-30 Patel Sanjiv President and CEO Grant or award 10b5-1 +3,056 $6.95 $21K 664,097

Page 1 of 27 · 534 trades